HeraMED Limited (ASX:HMD)
0.0390
-0.0010 (-2.50%)
Oct 27, 2026, 2:41 PM AEDT
HeraMED Market Cap
HeraMED has a market cap or net worth of 45.19 million as of October 27, 2026. It is the 33,241st most valuable company in the world and the 800th biggest in Australia. Its market cap has increased by 27.54% in one year.
Market Cap
45.19M
Enterprise Value
42.26M
Revenue
330.44K
Global Rank
Country Rank
#800 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 45.19M, an increase of 186.81%. That is a compound annual growth rate of 14.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 45.19M | 17.29% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 65.53M |
| SomnoMed | 62.63M |
| Epiminder | 57.42M |
| Compumedics | 47.94M |
| Cyclopharm | 47.15M |
| Cleo Diagnostics | 43.88M |
| Nova Eye Medical | 42.74M |
| Micro-X | 39.13M |